BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1596880)

  • 1. Antitumor activity of a novel nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine (CNDAC) against murine and human tumors.
    Tanaka M; Matsuda A; Terao T; Sasaki T
    Cancer Lett; 1992 May; 64(1):67-74. PubMed ID: 1596880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity and novel DNA-self-strand-breaking mechanism of CNDAC (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl) cytosine) and its N4-palmitoyl derivative (CS-682).
    Hanaoka K; Suzuki M; Kobayashi T; Tanzawa F; Tanaka K; Shibayama T; Miura S; Ikeda T; Iwabuchi H; Nakagawa A; Mitsuhashi Y; Hisaoka M; Kaneko M; Tomida A; Wataya Y; Nomura T; Sasaki T; Matsuda A; Tsuruo T; Kurakata S
    Int J Cancer; 1999 Jul; 82(2):226-36. PubMed ID: 10389757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleosides and nucleotides. 141. Chemical stability of a new antitumor nucleoside, 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in alkaline medium: formation of 2'-C-cyano-2'-deoxy-1-beta-D-ribo-pentofuranosylcytosine and its antitumor activity.
    Azuma A; Hanaoka K; Kurihara A; Kobayashi T; Miyauchi S; Kamo N; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1995 Aug; 38(17):3391-7. PubMed ID: 7650692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants in chemosensitivity of oncogene-transformed NIH3T3 cells to 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine.
    Zhang M; Endo Y; Sasaki T
    Int J Oncol; 1999 Mar; 14(3):543-9. PubMed ID: 10024689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.
    Azuma A; Nakajima Y; Nishizono N; Minakawa N; Suzuki M; Hanaoka K; Kobayashi T; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1993 Dec; 36(26):4183-9. PubMed ID: 8277499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo.
    Yoshida T; Endo Y; Obata T; Kosugi Y; Sakamoto K; Sasaki T
    Drug Metab Dispos; 2010 Oct; 38(10):1814-9. PubMed ID: 20587622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside.
    Matsuda A; Nakajima Y; Azuma A; Tanaka M; Sasaki T
    J Med Chem; 1991 Sep; 34(9):2917-9. PubMed ID: 1895307
    [No Abstract]   [Full Text] [Related]  

  • 8. Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine.
    Miura S; Yoshimura Y; Endo M; Machida H; Matsuda A; Tanaka M; Sasaki T
    Cancer Lett; 1998 Jul; 129(1):103-10. PubMed ID: 9714341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic liponucleotide analogs. II. Antitumor activity of CDP-diacylglycerol analogs containing the cytosine arabinoside moiety.
    Turcotte JG; Srivastava SP; Steim JM; Calabresi P; Tibbetts LM; Chu MY
    Biochim Biophys Acta; 1980 Sep; 619(3):619-31. PubMed ID: 7459369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and biochemical characterization of a 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC)-resistant variant of the human fibrosarcoma cell line HT-1080.
    Obata T; Endo Y; Tanaka M; Matsuda A; Sasaki T
    Cancer Lett; 1998 Jan; 123(1):53-61. PubMed ID: 9461018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
    Yamagami K; Fujii A; Arita M; Okumoto T; Sakata S; Matsuda A; Ueda T; Sasaki T
    Cancer Res; 1991 May; 51(9):2319-23. PubMed ID: 2015596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleoside conjugates. 7. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugates of ether lipids.
    Hong CI; An SH; Buchheit DJ; Nechaev A; Kirisits AJ; West CR; Berdel WE
    J Med Chem; 1986 Oct; 29(10):2038-44. PubMed ID: 3761322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the prolonged infusion of DFP-10917, a deoxycytidine analog, as a therapeutic strategy for the treatment of human tumor xenografts in vivo.
    Iizuka K; Zhang C; Eshima K; Jin C; Eshima K; Fukushima M
    Int J Oncol; 2018 Mar; 52(3):851-860. PubMed ID: 29344636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
    Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
    J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the conjugate between N4-(4-carboxybutyryl)-1-beta-D-arabinofuranosylcytosine and chitosan as a macromolecular prodrug of 1-beta-D-arabinofuranosylcytosine.
    Ichikawa H; Onishi H; Takahata T; Machida Y; Nagai T
    Drug Des Discov; 1993; 10(4):343-53. PubMed ID: 8148473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides.
    Obata T; Endo Y; Tanaka M; Uchida H; Matsuda A; Sasaki T
    Jpn J Cancer Res; 2001 Jul; 92(7):793-8. PubMed ID: 11473731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
    Hong CI; Kirisits AJ; Buchheit DJ; Nechaev A; West CR
    Cancer Drug Deliv; 1986; 3(2):101-13. PubMed ID: 3708534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyribonucleoside triphosphate pools and Ara-CTP levels in P388 murine leukemic cells treated with 1-B-D-arabinofuranosylcytosine-5'-stearylphosphate which is a newly synthesized derivative of 1-B-D-arabinofuranosylcytosine.
    Higashigawa M; Hori H; Ohkubo T; Kawasaki H; Yoshizumi T; Sakurai M
    Med Oncol Tumor Pharmacother; 1990; 7(4):223-6. PubMed ID: 2283889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-beta-D-Arabinofuranosylcytosine-5'-alkylphosphonophosphates and diphosphates: new orally active derivatives of ara-C.
    Brachwitz H; Bergmann J; Fichtner I; Thomas Y; Vollgraf C; Langen P; Berdel WE
    J Lipid Res; 1998 Jan; 39(1):162-72. PubMed ID: 9469595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K; Tsuruo T; Naganuma K; Tsukagoshi S; Sakurai Y
    Cancer Res; 1984 Jan; 44(1):172-7. PubMed ID: 6690034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.